Completed OBSERVATIONAL NCT05995756

Evaluate the Safety and Efficacy of Sinocare CGM System Regarding Real Time Glucose Level Monitoring

Evaluate the Safety and Efficacy of Sinocare CGM System Regarding Real Time Glucose

Sponsor: Sinocare

Updated 4 times since 2023 Last updated: Aug 29, 2023 Started: Dec 20, 2021 Primary completion: Jun 30, 2022 Completion: Jun 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Type 1 or Type 2 Diabetes, this trial is completed. The trial is conducted by Sinocare and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Oct 2023 — Jul 2024 [monthly]

Completed
Sep 2023 — Oct 2023 [monthly]

Completed

First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sinocare

Data source: Sinocare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China
• Changsha, China